Progress in Pharmacometrics Implementation and Regulatory Integration in Africa: A Systematic Review
Clinical Pharmacology & Therapeutics · 2024
DOI: 10.1002/cpt.3415 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Bonginkosi S'fiso Ndzamba und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of the Western Cape, Cape Town, South Africa. Hauptthemen laut MEDLINE: Drug Development. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The availability of clinical trial data, advocacy, and increased funding has facilitated the implementation of pharmacometrics in Africa, resulting in the establishment of additional training programs for pharmacometricians. This study conducted a systematic review to evaluate the progress made from the implementation of pharmacometrics in clinical drug development and its adoption into drug approval by regulatory authorities in Africa. We performed a comprehensive literature search using major databases such as PubMed and Google Scholar. The study included articles published until 2024, with no lower cutoff. Articles were excluded if not addressing the research question or of pharmacometrics studies done outside Africa with no collaboration with African researchers (study setting). For the review, a total of 121 articles were included for analysis. Among the reported pharmacometrics approaches, Population pharmacokinetics modeling approaches are the most used (95 (78.5%)). South Africa and Uganda researchers have the most research output in pharmacometrics in Africa (82 (89.1%) and 7 (7.61%), respectively), with the University of Cape Town (South Africa) producing the highest (71 (78.8%)) of all article in Africa. The most studied conditions are TB (43 (35.5%)), HIV (33 (27.3%), TB and HIV (22 (18.2%)), and malaria (12 (9.92%). Pharmacometrics is gaining momentum in Africa, and the progress made since inception will significantly improve the safety and efficacy of therapeutic agents used to treat HIV, TB, and other emerging conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Pharmacy, University of the Western Cape, Cape Town, South Africa.
- South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa.
- Department of Pharmacology & Toxicology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Samuel Egieyeh, Pius Fasinu
Zitieren
APA
Ndzamba, B. S., Egieyeh, S., & Fasinu, P. (2024). Progress in Pharmacometrics Implementation and Regulatory Integration in Africa: A Systematic Review. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3415
Vancouver
Ndzamba BS, Egieyeh S, Fasinu P. Progress in Pharmacometrics Implementation and Regulatory Integration in Africa: A Systematic Review. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3415
BibTeX
@article{Ndzamba2024,
author = {Ndzamba, Bonginkosi S'fiso and Egieyeh, Samuel and Fasinu, Pius},
title = {Progress in Pharmacometrics Implementation and Regulatory Integration in Africa: A Systematic Review},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
doi = {10.1002/cpt.3415}
}
EUVIMED